Lysergic acid hydroxyethylamide

Lysergic acid hydroxyethylamide (also known as LAH) is a derivative of lysergic acid. It is a member of the lysergamide family and has a similar structure to LSD.

Etymology[edit]

The name "Lysergic acid hydroxyethylamide" is derived from its chemical structure. "Lysergic acid" refers to the base compound, while "hydroxyethylamide" refers to the functional groups attached to the base compound.

Chemistry[edit]

Lysergic acid hydroxyethylamide is a derivative of lysergic acid, which is itself derived from the ergot fungus. It is a member of the lysergamide family, which also includes substances such as LSD, ALD-52, and 1P-LSD. Like other lysergamides, LAH is believed to act as a serotonin receptor agonist.

Pharmacology[edit]

The pharmacology of lysergic acid hydroxyethylamide is not well-studied. However, due to its structural similarity to other lysergamides, it is believed to act primarily as a serotonin receptor agonist. This means it binds to and activates the serotonin receptors in the brain, which are involved in mood, cognition, and perception.

Effects[edit]

The effects of lysergic acid hydroxyethylamide are not well-documented, as it is not commonly used recreationally or medically. However, based on its structural similarity to other lysergamides, it is likely to produce effects similar to those of LSD, including altered perception, hallucinations, and changes in thought processes.

Legal Status[edit]

The legal status of lysergic acid hydroxyethylamide varies by country. In many countries, it is considered a controlled substance due to its similarity to LSD.